How many insider trades does FilingIQ track for MNOV?

FilingIQ tracks 85 Form 4 insider transactions for MNOV (MEDICINOVA INC), covering filings from Jul 9, 2015 onwards. 3 of those were filed in the last 90 days.

Are MNOV insiders net buyers or net sellers?

Across the full Form 4 history for MNOV, 7 transactions (8%) were open-market purchases and 8 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MNOV insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MNOV in?

MEDICINOVA INC (MNOV) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $71.80M.

MNOV insider trading

NasdaqGM Healthcare

MEDICINOVA INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

8% / 9%

Market cap

$71.80M

About MEDICINOVA INC

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Company website: medicinova.com

MNOV insider activity at a glance

FilingIQ has scored 85 insider transactions for MNOV since Jul 9, 2015. The most recent filing in our index is dated Jun 23, 2026.

Across the full history, 7 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MNOV insider trades is 50.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MNOV trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,213

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

KYMR 178

Kymera Therapeutics, Inc.

First Tracks Biotherapeutics, Inc.

Frequently asked

How many insider trades does FilingIQ track for MNOV?: FilingIQ tracks 85 Form 4 insider transactions for MNOV (MEDICINOVA INC), covering filings from Jul 9, 2015 onwards. 3 of those were filed in the last 90 days.
Are MNOV insiders net buyers or net sellers?: Across the full Form 4 history for MNOV, 7 transactions (8%) were open-market purchases and 8 (9%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MNOV insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MNOV in?: MEDICINOVA INC (MNOV) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $71.80M.

Methodology & sources

Every MNOV insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.